--- title: "Healthcare Basket | Nifty Healthcare Momentum | RupeeCase" description: "10 momentum ranked stocks from the Nifty MidSmall Healthcare universe, rotated every week. A thematic index in your demat, 0.2% of traded value per rebalance." source_url: "https://www.rupeecase.com/strategies/healthcare-basket" --- Thematic, Nifty MidSmall Healthcare # Healthcare Basket thematic momentum strategy A healthcare momentum basket: 10 stocks from Nifty MidSmall Healthcare, rotated weekly. The healthcare thematic satellite. **Written for** growth-oriented investors comfortable with double-digit drawdowns. **High** risk band [Invest in Healthcare Basket](https://invest.rupeecase.com/signup?strategy=healthcare-basket) [Compare strategies](/compare) 01At a glance ## Healthcare Basket in four numbers. CAGR**15.19%**Model, back tested Max drawdown**−33.29%**Model, back tested Minimum investment**₹36K**About ₹36,000 Fee per rebalance**0.2%**Of traded value, nothing else Healthcare Basket, model**₹210**Nifty 50 TRI, 9.80% CAGR line**₹162** 100 150 200 ₹100 in the model in May 2021 became ₹210 by Jul 2026; the Nifty 50 TRI line reached ₹162. Model, back tested. As of 27 Apr 2026. After charges, log scale. Not a promise of future returns. 02Three steps ## Compare. Validate. Invest. 1. ### Invest Link your broker and approve each rebalance. Stocks stay in your own demat; RupeeCase never holds your money. [Invest in Healthcare Basket](https://invest.rupeecase.com/signup?strategy=healthcare-basket) 2. ### Invest Link your broker and approve each rebalance. Stocks stay in your own demat; RupeeCase never holds your money. [Invest in Healthcare Basket](https://invest.rupeecase.com/signup?strategy=healthcare-basket) 3. ### Invest Link your broker and approve each rebalance. Stocks stay in your own demat; RupeeCase never holds your money. [Invest in Healthcare Basket](https://invest.rupeecase.com/signup?strategy=healthcare-basket) 03Factsheet ## Healthcare Basket factsheet Every figure behind the four numbers, in seven parts. Return figures are model, back tested and after charges; each block names its date. Print [PDF factsheet](https://www.rupeecase.com/strategies/factsheets/healthcare-basket) Performance Holdings and sectors Rebalances Risk metrics Methodology Costs Documents ### PerformanceYears, months, rolling returns, falls, the stress test ### Performance #### Calendar year returns * 2021from May**+4.4%** * 2022**−19.6%** * 2023**+57.2%** * 2024**+40.0%** * 2025**+0.6%** * 2026to May**+16.2%** Model, back tested, after charges, 2021 to May 2026. Not a promise of future returns. #### What an amount would have become One time Every month Amount, ₹ You put in₹36,000 Model value Gain Model, back tested: the published monthly model returns after charges, May 2021 to May 2026 (61 months). A back test, not a promise of future returns. #### Stress test: drag through the falls Move across the record to read how far the model sat below its last peak, and how long it took to climb back. Month**Jun 2022** Below the last peak**−30.8%** Back to the peak Model value, log scaleBelow the last peak Month on the record Deepest falls, daily record **−33.3%**Jul 2021, 735 days to recover **−19.4%**Dec 2024, 189 days to recover **−11.3%**Oct 2025, 175 days to recover **−10.2%**Mar 2024, 112 days to recover Model, back tested. As of 27 Apr 2026. The scrub reads month end model values from May 2021 to Jul 2026, so its falls read shallower than the daily figures on the buttons; days are counted between month ends. Drawdowns of similar size can happen again. High risk band. #### Monthly returns | Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2021 | Janno data | Febno data | Marno data | Aprno data | May2.8 | Jun3.0 | Jul3.2 | Aug−0.8 | Sep−1.7 | Oct−8.3 | Nov3.6 | Dec3.2 | Year+4.4% | | 2022 | Jan−7.5 | Feb−6.3 | Mar2.7 | Apr−2.6 | May−10.1 | Jun−7.1 | Jul9.7 | Aug−1.8 | Sep−0.2 | Oct4.4 | Nov1.9 | Dec−2.9 | Year−19.6% | | 2023 | Jan−6.5 | Feb0.2 | Mar3.9 | Apr7.9 | May5.5 | Jun9.8 | Jul7.0 | Aug2.2 | Sep3.4 | Oct−6.3 | Nov12.4 | Dec8.7 | Year+57.2% | | 2024 | Jan4.7 | Feb5.4 | Mar−6.4 | Apr1.7 | May−5.7 | Jun12.1 | Jul7.4 | Aug12.8 | Sep−3.0 | Oct1.2 | Nov6.8 | Dec−0.7 | Year+40.0% | | 2025 | Jan−8.6 | Feb−11.0 | Mar11.5 | Apr0.8 | May1.0 | Jun10.5 | Jul5.1 | Aug−4.9 | Sep0.2 | Oct4.8 | Nov−5.1 | Dec−1.1 | Year+0.6% | | 2026 | Jan−5.4 | Feb7.7 | Mar−2.6 | Apr8.9 | May7.4 | Junno data | Julno data | Augno data | Sepno data | Octno data | Novno data | Decno data | Year to date+16.2% | Model, back tested, after charges. Each cell is one calendar month, in percent. Not a promise of future returns. #### Rolling returns ##### Any 1 year Worst−28.6% Median+22.3% Best+85.5% Positive76%of 51 windows Return over each 12 month window. ##### Any 3 years Worst+8.4% Median+28.1% Best+35.7% Positive100%of 27 windows CAGR over each 36 month window. Model, back tested, from the month end model values, May 2021 to Jul 2026. Not a promise of future returns. #### Deepest falls 1. **−7.13%**6 Oct 2023 to 3 Nov 2023*28 days* 2. **−7.13%**6 Oct 2023 to 3 Nov 2023*28 days* 3. **−7.13%**6 Oct 2023 to 3 Nov 2023*28 days* 4. **−7.13%**6 Oct 2023 to 3 Nov 2023*28 days* 5. **−7.13%**6 Oct 2023 to 3 Nov 2023*28 days* Model, back tested, daily record over rolling 5 years: from the peak to the low, and the days until the record was back at that peak. ### Holdings and sectors10 holdings, 2 sectors ### Holdings and sectors #### 10 holdings * Equity**100%** * FORTIS**10.9%** * NATCOPHARM**10.7%** * WOCKPHARMA**10.7%** * GLENMARK**10.4%** * COHANCE**10.3%** * AUROPHARMA**10.3%** * GRANULES**10.0%** * SAILIFE**9.8%** * LAURUSLABS**8.8%** * ONESOURCE**8.2%** [Live quantities, prices and book values are in the app](https://invest.rupeecase.com/signup?strategy=healthcare-basket) Weights on the rebalance day, 11 May 2026; they drift with prices until the next rebalance. Model portfolio, not a recommendation to buy or sell any stock. #### Sector allocation * Pharma & Healthcare**60.2%** * Other, not yet mapped**39.8%** 2 sectors in the equity sleeve; the largest mapped sector is Pharma & Healthcare at 60.2%, and 39.8% of the sleeve is not yet in the sector map. 100% pharma and healthcare by design. Mid and small cap specialty pharma, hospitals, life sciences, and CDMOs. No single-name allocation above ~11%. Sector map curated against NSE listings. #### Sector weight by year | Sector | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Now | | --- | --- | --- | --- | --- | --- | --- | --- | | Pharma & Healthcare | 26 | 26 | 28 | 35 | 27 | 59 | 55 | | Other, not yet mapped | 74 | 74 | 72 | 65 | 73 | 41 | 45 | 261 published rebalances, 2 sectors touched, 2 held on the latest list (8 May 2026). Each cell is the average weight that year, equal weighted at the stock level; darker is a higher weight. ### Rebalances261 published, latest 8 May 2026 ### Rebalances #### The rebalance record published rebalances261 first in the record14 May 2021 52 a yearEvery week latest published8 May 2026 Rebalances run on a fixed calendar; you approve each one before your broker places the orders. #### Latest rebalance, 8 May 2026 Against the list of 1 May 2026: **1 in**, **3 out**, 10 held, 11 on the list. ##### In * SAILIFE ##### Out * LUPIN * JBCHEPHARM * ASTERDM ##### Held * COHANCE * ONESOURCE * GRANULES * AUROPHARMA * GLENMARK * NATCOPHARM * WOCKPHARMA * FORTIS * LAURUSLABS * POLYMED Model portfolio, back tested rebalance record. Entered plus held is that date's list size, which can differ from the 10 stock target. Tickers are not recommendations. #### Recent rebalances | Date | On the list | In | Out | | --- | --- | --- | --- | | 8 May 2026 | 11 | +1 | −3 | | 1 May 2026 | 13 | +3 | −1 | | 24 Apr 2026 | 11 | +1 | 0 | | 17 Apr 2026 | 10 | 0 | −1 | | 10 Apr 2026 | 11 | +1 | −1 | | 3 Apr 2026 | 11 | +1 | −1 | | 27 Mar 2026 | 11 | +1 | 0 | | 20 Mar 2026 | 10 | 0 | −2 | | 13 Mar 2026 | 12 | +2 | −1 | | 6 Mar 2026 | 11 | +1 | −3 | | 27 Feb 2026 | 13 | +3 | −2 | | 20 Feb 2026 | 12 | +2 | 0 | [Every rebalance with its names](/rebalance/healthcare-basket/)[Rebalance history, CSV](/data/rebalances/healthcare-basket.csv) Names on the list, names in and names out at each date; the history page and the CSV have every name. #### Sector shifts of 10 points or more 1. 14 Jun 2024Other, not yet mapped **−15 pts**, Pharma & Healthcare **+15 pts** 2. 14 Jun 2024Other, not yet mapped **−15 pts**, Pharma & Healthcare **+15 pts** 3. 14 Jun 2024Other, not yet mapped **−15 pts**, Pharma & Healthcare **+15 pts** 4. 14 Jun 2024Other, not yet mapped **−15 pts**, Pharma & Healthcare **+15 pts** 5. 14 Jun 2024Other, not yet mapped **−15 pts**, Pharma & Healthcare **+15 pts** 6. 14 Jun 2024Other, not yet mapped **−15 pts**, Pharma & Healthcare **+15 pts** 11 such shifts in 261 rebalances; the latest six. Equity sleeve, equal weighted at the stock level. ### Risk metricsSharpe 0.89, volatility 19.44% ### Risk metrics #### Healthcare Basket against the Nifty 50 | Metric | Healthcare Basket | Nifty 50 | | --- | --- | --- | | Sharpe ratio | 0.89 | 0.73 | | Sortino ratio | 0.89 | 0.70 | | Calmar ratio | 0.50 | 0.58 | | Volatility, a year | 19.44% | 14.04% | | Max drawdown | −33.29% | −16.92% | | Best week | +8.24% | +6.36% | | Worst week | −9.01% | −6.33% | | Weeks up | 57.47% | 57.47% | | Average up week | +2.10% | +1.49% | | Average down week | −2.05% | −1.57% | Model, back tested, after charges. Weekly figures over the rolling 5 years window to 27 Apr 2026; the Nifty 50 over the same window. Not a promise of future returns. #### Risk band **High** on a scale from Low to Very High Deepest model fall−33.29% Time horizon5 years or longer. Drawdowns of 33% have happened in the backtest and can happen again. Capital you might need within 12 months should not be here. ##### Walk the risk band [One step safer (Moderately High)Dynamic Asset AllocatorCAGR 45.2%, Sharpe 2.32, max drawdown −10.6%](/strategies/dynamic-asset-allocator)[One step bolder (Very High)5Paisa Focused Alpha 5CAGR 54.1%, Sharpe 1.60, max drawdown −24.2%](/strategies/5paisa-focused-alpha-5) CAGR, Sharpe and max drawdown on the cards: Model, back tested. As of 27 Apr 2026. [Take the risk profile](/risk-profile) to see which bands sit within yours. ### MethodologyNifty MidSmall Healthcare, every week ### Methodology #### How it works 1. 4**Rebalance**Every week the model runs again end to end. Names that fall out of the top 10 are sold; new entrants are bought. The full list is published at every rebalance. 2. 4**Rebalance**Every week the model runs again end to end. Names that fall out of the top 10 are sold; new entrants are bought. The full list is published at every rebalance. 3. 4**Rebalance**Every week the model runs again end to end. Names that fall out of the top 10 are sold; new entrants are bought. The full list is published at every rebalance. 4. 4**Rebalance**Every week the model runs again end to end. Names that fall out of the top 10 are sold; new entrants are bought. The full list is published at every rebalance. #### Configuration UniverseNifty MidSmall Healthcare TypeThematic SleevesEquity 100 Holdings10, equal weight RebalanceEvery week, 52 a year Max stock price₹5,000 Risk bandHigh BenchmarkNifty 50; charts draw the Nifty 50 TRI as a CAGR line Minimum capitalAbout ₹36,000 Back test from7 May 2021 Metrics windowRolling 5 years PricesNSE BhavCopy; the back test deducts brokerage, STT, exchange charges and GST #### Why Healthcare Basket The dashboard on sample data The second thematic satellite card on the lineup, alongside Energy Basket. The index screens the Nifty MidSmall Healthcare universe for the top 10 momentum-ranked stocks priced under 5000, holds them equal-weighted at roughly 10% each, and rotates every week. It rotates weekly like Energy Basket, but the universe is a different sector: mid and small cap pharma, hospitals, and life sciences. Healthcare runs on its own cycle, capex, approvals, and pricing rather than commodities, which is exactly why it earns a satellite slot next to an energy tilt. Ten names from one sector means the card moves as a bloc when sector-wide news lands. The momentum screen decides which ten. The sector decides the weather. This is NOT a core holding. Single-sector concentration risk is real, pharma stocks move together when USFDA decisions, domestic price caps, or hospital reimbursement rules shift. Investors without that view should put the same capital into Allcap or Midcap Smallcap instead. ##### Key takeaways * Thematic healthcare momentum on Nifty MidSmall Healthcare * 10 stocks equal-weighted, rotated weekly * A sector cycle that runs on approvals and pricing, not commodities * Satellite sizing only: 5 to 10% of equity, alongside Energy Basket A description of the strategy, not a recommendation. Decide your own allocation, or ask a SEBI registered investment adviser. #### Who it is written for Written forGrowth-oriented investors comfortable with double-digit drawdowns CapitalAbout ₹36,000, one share of every holding at recent prices. More capital buys more of each holding and tracks the model weights more closely. #### How the rule was built Machine learning is used in research to search and optimise the model behind each strategy: which signals rank the universe, how many names to hold and how often to rebalance, tested out of sample. The rule that ships is then frozen and published, so the live strategy is a fixed, readable algorithm, not a black box that changes on its own. [The engine, tick by tick execution data and the audit trail](/technology) #### Learn the mechanics * [Factor timingwhen sector bets work](/learn/path-3/module-3-7-factor-timing-and-cycles) * [Factor investing in Indiathe evidence](/learn/path-3/module-3-8-factor-investing-india-evidence) * [Momentum factorthe engine behind these strategies](/learn/path-3/module-3-1-momentum-factor-deep-dive) * [How back testing worksreading the five year numbers honestly](/learn/path-2/module-2-4-how-backtesting-works) Free modules from the RupeeCase Learn library. No sign up. ### Costs0.2% of traded value per rebalance ### Costs #### One fee per rebalance **0.2%**of traded value, charged only when a rebalance trades * No subscription, no AUM fee, no performance fee. * No lock in: the stocks sit in your own demat and you can sell any day the market is open. * Broker side charges (brokerage, STT, exchange charges, GST) are separate and paid to your broker. #### A year on the minimum Minimum capital₹36,000 Rebalances a year52, every week Book traded each time30%, an assumption Platform fee a year, about₹1,1203.11% of capital Higher turnover or more capital raises the fee in proportion. #### Costs inside the back test Gross return+141.80%before costs Estimated costs−25.89 ptsbrokerage, STT and taxes Net return+115.91%after costs Nifty 50, same window+59.62%cumulative Model, back tested, cumulative over the rolling 5 years window to 27 Apr 2026. Net is gross minus estimated costs, as on the current factsheet. Not a promise of future returns. #### Work it out for your amount [Fee calculator](/fee-calculator)[Pricing, with a worked example](/pricing) ### DocumentsPrint, PDF factsheet, rebalance CSV ### Documents #### Download and print * **Print this factsheet**Or save it as a PDF from the print dialog. Every section above, on clean pages. * [Download the PDF factsheetThe two page factsheet on the current site; enter your email to have a copy sent.](https://www.rupeecase.com/strategies/factsheets/healthcare-basket) * [Rebalance history, CSVEvery published list, 261 rebalances, 14 May 2021 to 8 May 2026.](/data/rebalances/healthcare-basket.csv) * [Rebalance history pageEach rebalance with what came in and what went out.](/rebalance/healthcare-basket/) * [This strategy as plain textMarkdown, for reading tools and AI assistants.](/strategies/healthcare-basket.md) * [DisclaimersHow the model figures are made and what they are not.](/disclaimers) RupeeCase is a technology platform, not a fund, a PMS or a SEBI registered investment adviser. Model, back tested. As of 27 Apr 2026. Model figures are after estimated charges and are not actual client returns. Past performance does not guarantee future returns; capital can be lost. 04Questions ## Before you commit capital. ### What is the Healthcare Basket strategy? 10 stocks from Nifty MidSmall Healthcare, rotated weekly. The defensive thematic satellite. It selects the top 10 momentum names from Nifty MidSmall Healthcare and rebalances every week. ### What is the minimum investment for Healthcare Basket? About ₹36,000, enough to hold one share of every name in the current book at recent prices. The figure moves with the prices of the holdings. ### How does Healthcare Basket compare to the Nifty 50? Healthcare Basket shows a model CAGR of 15.19% against 9.80% for the Nifty 50 TRI CAGR line (Jan 2021 to Jul 2026), with a Sharpe ratio of 0.89. Model, back tested. As of 27 Apr 2026. Past performance does not guarantee future returns. ### What is the worst drawdown Healthcare Basket has experienced? 33.29% peak to trough in the model record. The deepest period ran 735 days, from 23 Jul 2021 to 28 Jul 2023. Model, back tested. As of 27 Apr 2026. Drawdowns of similar size can happen again, so size the position for it. ### What are the fees on Healthcare Basket? 0.2% of traded value per rebalance. No subscription, no AUM fee, no performance fee. On the minimum capital of ₹36,000, the platform fee works out to about ₹1,120 a year (3.12% of capital). Assumptions: 52 rebalances a year (every week), 30% of the book traded at each rebalance, 0.2% of traded value. Higher turnover or more capital raises the fee in proportion. Broker side charges (brokerage, STT, exchange charges, GST) are separate. ### Can I exit Healthcare Basket at any time? Yes. No lock-in. Holdings sit in your own broker demat account and you can sell any name on any market day. Switching strategies or pausing the rebalance is a one-click action on the platform. 05Same family ## Thematic: Energy and healthcare. [All 18 strategies](/strategies/#sxPick) [HighThematic Energy Basket CNX Energy, 10 stocks, every week CAGR, model33.12%Max DD−39.5%From₹75K High risk, thematic](/strategies/energy-basket) CAGR and Max DD on the cards: Model, back tested. As of 27 Apr 2026. Explore next ## Go deeper on this strategy. * [TierThematic satellite tier strategies2 strategies grouped by job](/strategies/by-tier/thematic) * [SectorHealthcare stocksNSE sector across the 18 index algos](/sectors/healthcare) * [StockCOHANCE, Cohance LifesciencesOn 5 of 18 latest lists](/stocks/COHANCE) * [Free module 7.6Corporate Earnings Cycle in India10 min read](/learn/path-7/module-7-6-corporate-earnings-cycle-india) * [Free module 4.2Position Sizing8 min read](/learn/path-4/module-4-2-position-sizing) Ready when you are ## Healthcare Basket 15.19% CAGR, model, back tested. About ₹36K to start. Every week, you approve each one. [Invest in Healthcare Basket](https://invest.rupeecase.com/signup?strategy=healthcare-basket) [Compare strategies](/compare) 0.2% of traded value per rebalance. No AUM fee, no lock in. Line behind: the Healthcare Basket model record, after charges, as of 27 Apr 2026. Not a promise of future returns.